• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Nomograms-based prediction of overall and cancer-specific survivals for patients with chromophobe renal cell carcinoma.基于列线图预测嫌色性肾细胞癌患者的总生存期和癌症特异性生存期
Exp Biol Med (Maywood). 2021 Mar;246(6):729-739. doi: 10.1177/1535370220977107. Epub 2020 Dec 10.
2
Prognostic nomograms and Aggtrmmns scoring system for predicting overall survival and cancer-specific survival of patients with kidney cancer.用于预测肾癌患者总生存期和癌症特异性生存期的预后列线图及Aggtrmmns评分系统。 需注意,原文中的“Aggtrmmns”可能有误,不太明确其准确含义。
Cancer Med. 2020 Apr;9(8):2710-2722. doi: 10.1002/cam4.2916. Epub 2020 Feb 22.
3
The nomograms for predicting overall and cancer-specific survival in elderly patients with early-stage lung cancer: A population-based study using SEER database.基于 SEER 数据库的人群研究:用于预测老年早期肺癌患者总生存和癌症特异生存的列线图。
Front Public Health. 2022 Sep 8;10:946299. doi: 10.3389/fpubh.2022.946299. eCollection 2022.
4
Nomogram predicting overall survival of rectal squamous cell carcinomas patients based on the SEER database: A population-based STROBE cohort study.基于监测、流行病学和最终结果(SEER)数据库预测直肠鳞状细胞癌患者总生存期的列线图:一项基于人群的加强观察性研究报告(STROBE)队列研究
Medicine (Baltimore). 2019 Nov;98(46):e17916. doi: 10.1097/MD.0000000000017916.
5
Prognostic nomograms based on log odds of positive lymph nodes for patients with renal cell carcinoma: A retrospective cohort study.基于淋巴结阳性对数优势比的肾细胞癌患者预后列线图:一项回顾性队列研究。
Int J Surg. 2018 Dec;60:28-40. doi: 10.1016/j.ijsu.2018.10.038. Epub 2018 Oct 30.
6
Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.列线图预测Ⅰ期老年小细胞肺癌患者生存的建立与验证。
Bosn J Basic Med Sci. 2021 Oct 1;21(5):632-641. doi: 10.17305/bjbms.2020.5420.
7
A prognostic nomogram for the cancer-specific survival of patients with upper-tract urothelial carcinoma based on the Surveillance, Epidemiology, and End Results Database.基于监测、流行病学和最终结果数据库的上尿路上皮癌患者癌症特异性生存的预后列线图。
BMC Cancer. 2020 Jun 8;20(1):534. doi: 10.1186/s12885-020-07019-5.
8
Nomograms for predicting overall and cancer-specific survival of patients with chromophobe renal cell carcinoma after nephrectomy: a retrospective SEER-based study.基于 SEER 的回顾性研究:预测肾切除术治疗肾嫌色细胞癌患者总生存和癌症特异生存的列线图。
BMJ Open. 2022 Sep 1;12(9):e062129. doi: 10.1136/bmjopen-2022-062129.
9
Prognostic Factors and a Nomogram Predicting Overall Survival and Cancer-Specific Survival for Patients with Collecting Duct Renal Cell Carcinoma.预测肾集合管细胞癌患者总生存和癌症特异性生存的预后因素和列线图。
Biomed Res Int. 2021 Nov 11;2021:6736008. doi: 10.1155/2021/6736008. eCollection 2021.
10
Development and Validation of a Competitive Risk Model in Elderly Patients With Chromophobe Cell Renal Carcinoma: A Population-Based Study.《老年嗜铬细胞瘤肾细胞癌患者竞争风险模型的建立与验证:一项基于人群的研究》。
Front Public Health. 2022 Feb 22;10:840525. doi: 10.3389/fpubh.2022.840525. eCollection 2022.

引用本文的文献

1
Are We Accurately Predicting Mortality in Renal Cancer? A Systematic Review of Prognostic Models.我们是否准确预测了肾癌的死亡率?预后模型的系统评价。
J Clin Med. 2025 Aug 19;14(16):5851. doi: 10.3390/jcm14165851.
2
Critical Appraisal of Leibovich 2018 and GRANT Models for Prediction of Cancer-Specific Survival in Non-Metastatic Chromophobe Renal Cell Carcinoma.对Leibovich 2018模型和GRANT模型预测非转移性嫌色细胞肾细胞癌特异性癌症生存率的批判性评估
Cancers (Basel). 2023 Apr 5;15(7):2155. doi: 10.3390/cancers15072155.
3
Nomograms for predicting overall and cancer-specific survival of patients with chromophobe renal cell carcinoma after nephrectomy: a retrospective SEER-based study.基于 SEER 的回顾性研究:预测肾切除术治疗肾嫌色细胞癌患者总生存和癌症特异生存的列线图。
BMJ Open. 2022 Sep 1;12(9):e062129. doi: 10.1136/bmjopen-2022-062129.
4
Development and Validation of a Competitive Risk Model in Elderly Patients With Chromophobe Cell Renal Carcinoma: A Population-Based Study.《老年嗜铬细胞瘤肾细胞癌患者竞争风险模型的建立与验证:一项基于人群的研究》。
Front Public Health. 2022 Feb 22;10:840525. doi: 10.3389/fpubh.2022.840525. eCollection 2022.
5
Development and Validation of a Predictive Model to Evaluate the Risk of Bone Metastasis in Kidney Cancer.评估肾癌骨转移风险预测模型的开发与验证
Front Oncol. 2021 Nov 25;11:731905. doi: 10.3389/fonc.2021.731905. eCollection 2021.

本文引用的文献

1
Nomograms for predicting overall and cancer-specific survival in patients with papillary renal cell carcinoma: a population-based study using SEER database.预测乳头状肾细胞癌患者总生存期和癌症特异性生存期的列线图:一项基于监测、流行病学和最终结果(SEER)数据库的人群研究
Transl Androl Urol. 2020 Jun;9(3):1146-1158. doi: 10.21037/tau-19-807.
2
Development and validation of an integrative methylation signature and nomogram for predicting survival in clear cell renal cell carcinoma.用于预测透明细胞肾细胞癌患者生存情况的综合甲基化特征及列线图的开发与验证
Transl Androl Urol. 2020 Jun;9(3):1082-1098. doi: 10.21037/tau-19-853.
3
Predictive Nomogram for Midterm to Long-Term Prognosis in Patients with Papillary Renal Cell Carcinoma Based on Data from the Surveillance, Epidemiology, and End Results (SEER) Program.基于监测、流行病学和最终结果(SEER)计划数据的乳头状肾细胞癌患者中期至长期预后预测列线图。
Med Sci Monit. 2020 Jun 22;26:e921859. doi: 10.12659/MSM.921859.
4
Effect of stage and grade migration on cancer specific mortality in renal cell carcinoma patients, according to clear cell vs. non-clear cell histology: A contemporary population-based analysis.根据透明细胞与非透明细胞组织学,分期和分级迁移对肾细胞癌患者癌症特异性死亡率的影响:一项基于人群的当代分析。
Urol Oncol. 2020 May;38(5):506-514. doi: 10.1016/j.urolonc.2020.02.004. Epub 2020 Mar 2.
5
Sites of synchronous distant metastases and prognosis in prostate cancer patients with bone metastases at initial diagnosis: a population-based study of 16,643 patients.初诊时伴有骨转移的前列腺癌患者同步远处转移部位与预后:一项基于16643例患者的人群研究
Clin Transl Med. 2019 Nov 29;8(1):30. doi: 10.1186/s40169-019-0247-4.
6
Combined Immunohistochemistry for the "Three 7" Markers (CK7, CD117, and Claudin-7) Is Useful in the Diagnosis of Chromophobe Renal Cell Carcinoma and for the Exclusion of Mimics: Diagnostic Experience from a Single Institution.联合免疫组化检测“三个 7 标记物”(CK7、CD117 和 Claudin-7)有助于诊断嫌色细胞性肾细胞癌并排除其类似物:单中心诊断经验。
Dis Markers. 2019 Oct 13;2019:4708154. doi: 10.1155/2019/4708154. eCollection 2019.
7
Clinicopathologic features associated with survival after cytoreductive nephrectomy for nonclear cell renal cell carcinoma.与肾透明细胞外肾细胞癌患者细胞减灭性肾切除术后生存相关的临床病理特征。
Urol Oncol. 2019 Nov;37(11):811.e9-811.e16. doi: 10.1016/j.urolonc.2019.07.011. Epub 2019 Sep 12.
8
Surgical intervention in renal cell carcinoma patients with lung and bronchus metastasis is associated with longer survival time: a population-based analysis.对伴有肺和支气管转移的肾细胞癌患者进行手术干预与更长的生存时间相关:一项基于人群的分析。
Ann Transl Med. 2019 Jul;7(14):323. doi: 10.21037/atm.2019.06.02.
9
Lymph Node Density as an Independent Prognostic Factor in Node-Positive Renal-Cell Carcinoma: Results From the Surveillance, Epidemiology, and End Results Program.淋巴结密度作为淋巴结阳性肾细胞癌的独立预后因素:来自监测、流行病学和最终结果计划的结果。
Clin Genitourin Cancer. 2019 Oct;17(5):e968-e980. doi: 10.1016/j.clgc.2019.05.011. Epub 2019 May 27.
10
Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma.更新的欧洲泌尿外科学会肾癌指南:免疫检查点抑制是转移性透明细胞肾细胞癌一线治疗的新支柱。
Eur Urol. 2019 Aug;76(2):151-156. doi: 10.1016/j.eururo.2019.05.022.

基于列线图预测嫌色性肾细胞癌患者的总生存期和癌症特异性生存期

Nomograms-based prediction of overall and cancer-specific survivals for patients with chromophobe renal cell carcinoma.

作者信息

Chen Chunyang, Geng Xinyu, Liang Rui, Zhang Dongze, Sun Meiyun, Zhang Guangbo, Hou Jianquan

机构信息

Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou 215006, People's Republic of China.

Jiangsu Institute of Clinical Immunology, The First Affiliated Hospital of Soochow University, Suzhou 215006, People's Republic of China.

出版信息

Exp Biol Med (Maywood). 2021 Mar;246(6):729-739. doi: 10.1177/1535370220977107. Epub 2020 Dec 10.

DOI:10.1177/1535370220977107
PMID:33302735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7988723/
Abstract

This study built and tested two effective nomograms for the purpose of predicting cancer-specific survival and overall survival of chromophobe renal cell carcinoma (chRCC) patients. Multivariate Cox regression analysis was employed to filter independent prognostic factors predictive of cancer-specific survival and overall survival, and the nomograms were built based on a training set incorporating 2901 chRCC patients in a retrospective study (from 2004 to 2015) downloaded from the surveillance, epidemiology, and end results (SEER) database. The nomograms were verified on a validation cohort of 1934 patients, subsequently the performances of the nomograms were examined according to the receiver operating characteristic curve, calibration curves, the concordance (C-index), and decision curve analysis. The results showed that tumor grade, AJCC and N stages, race, marital status, age, histories of chemotherapy, radiotherapy and surgery were the individual prognostic factors for overall survival, and that AJCC, N and SEER stages, histories of surgery, radiotherapy and chemotherapy, age, tumor grade were individual prognostic factors for cancer-specific survival. According to C-indexes, receiver operating characteristic curves, and decision curve analysis outcomes, the nomograms showed a higher accuracy in predicting overall survival and OSS when compared with TNM stage and SEER stage. All the calibration curves were significantly consistent between predictive and validation sets. In this study, the nomograms, which were validated to be highly accurate and applicable, were built to facilitate individualized predictions of the cancer-specific survival and overall survival to patients diagnosed with chRCC between 2004 and 2015.

摘要

本研究构建并测试了两个有效的列线图,用于预测嫌色肾细胞癌(chRCC)患者的癌症特异性生存率和总生存率。采用多变量Cox回归分析来筛选预测癌症特异性生存率和总生存率的独立预后因素,并基于一项回顾性研究中的训练集构建列线图,该训练集纳入了从监测、流行病学和最终结果(SEER)数据库下载的2901例chRCC患者(2004年至2015年)。在1934例患者的验证队列上对列线图进行验证,随后根据受试者工作特征曲线、校准曲线、一致性(C指数)和决策曲线分析来检验列线图的性能。结果显示,肿瘤分级、美国癌症联合委员会(AJCC)和N分期、种族、婚姻状况、年龄、化疗史、放疗史和手术史是总生存率的个体预后因素,而AJCC、N和SEER分期、手术史、放疗史和化疗史、年龄、肿瘤分级是癌症特异性生存率的个体预后因素。根据C指数、受试者工作特征曲线和决策曲线分析结果,与TNM分期和SEER分期相比,列线图在预测总生存率和癌症特异性生存率方面具有更高的准确性。预测集和验证集之间所有校准曲线均显著一致。在本研究中,构建了经验证具有高度准确性和适用性的列线图,以促进对2004年至2015年间诊断为chRCC的患者进行癌症特异性生存率和总生存率的个体化预测。